And Tarceva, a pill Genentech co-markets with OSI Pharmaceuticals (nasdaq: OSIP - news - people ), was the first drug to extend the lives of pancreatic cancer patients when added to Eli Lilly 's (nyse: LLY - news - people ) Gemzar.
FORBES: Genentech's Triumph